Skip to main content
. 2019 Nov 19;24(22):4190. doi: 10.3390/molecules24224190
Compound Name, Synonyms
3-O-Ac-[18F]FcyF (10) 3-O-[18F]acetylcyclofoxy, 3-O-Acetyl-6-deoxy-6-beta-[18F]fluoronaltrexone
β-Endorphin Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val- Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr-Lys-Lys-Gly-Glu
CAS RN: [61214-51-5]
BEMP 2-tert-butylimino-2-diethylamino-1,3-dimethyl-perhydro-1,3,2-diazaphosphorine
CAS RN: [98015-45-3]
[11C]BPN (14) [11C]buprenorphine, [6-O-methyl-11C]buprenorphine
Caf carfentanil, 1-(2-phenylethyl)-4-[(1-oxopropyl)phenylamino]-4-piperidine
carboxylic acid methyl ester, R-31,833, 4-carboxymethyl-fentanyl,
CAS RN: [59708-52-09]
[11C]Caf (8) [11C]carfentanil
[3H]DAMGO [3,5-3H]Tyr-D-Ala-Gly-(NMe)Phe-Gly-ol
DBU 1,8-diazabicyclo[5.4.0]undec-7-ene, CAS RN: [6674-22-2]
DIPEA ethyldiisopropylamine, N,N-diisopropylamine, Hünig’s base
DMF N,N-dimethylformamide
[11C]DPN (15) [11C]diprenorphine, [6-O-methyl-11C]diprenorphine
dppf 1,1’-ferrocenediyl-bis(diphenylphosphine), CAS RN: [121450-46-8]
Dynorphin A [1-17] Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-T rp-Asp-Asn-Gln CAS RN: [80448-90-4]
Dynorphin A [1-8] Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile, CAS RN: [75790-53-3]
Dynorpin B [1-13] Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Gln-Phe-Lys-Val-Val-Thr,
CAS RN: [83335-41-5]
[11C]EKAP (27) (R)-(methyl-11C) 4-(2-(3,4-dichlorophenyl)acetyl)-3-((diethylamino)methyl) piperazine-1-carboxylate
cyF cyclofoxy, 6-deoxy-6β-[18F]fluoro-naltrexone,
N-cyclopropylmethyl-6-deoxy-6β-fluoro-noroxymorphone,
17-cyclopropylmethyl-4,5α-epoxy-6β-fluoro-morphinan-3,14-diol
CAS RN: [103223-57-0]
[18F]FcyF (11) [18F]cyclofoxy, 6-Deoxy-6-β-[18F]fluoro-naltrexone,
N-cyclopropylmethyl-6-deoxy-6β-[18F]fluoro-noroxymorphone,
CAS RN: [103223-58-1]
FDOPA 6-fluoro-L-dopa, 2-Fluoro-5-hydroxy-L-tyrosine, CAS RN: [144334-59-8]
[18F]FE-DPN (16) 6-O-(2-[18F]fluoroethyl)-6-O-desmethyl-diprenorphine
[11C]FEKAP (28) (R)-(methyl-11C)4-(2-(3,4-dichlorophenyl)acetyl)-3-((ethyl(2-fluoroethyl)amino) methyl)piperazine-1-carboxylate
[18F]FE-BPN (19) 6-O-(2-[18F]fluoroethyl)-6-O-desmethyl-buprenorphine
[18F]FP-norBPN (21) N17-(3-[18F]fluoropropyl)-nor-buprenorphine
[18F]FP-norDPN (20) N17-(3-[18F]fluoropropyl)-nor-diprenorphine
[18F]FE-NTI (23) [18F]fluoroethyl-naltrindole, N1’-(2-[18F]Fluoroethyl)-naltrindole, [18F]BU97001
[18F]FE-PEO (17) 6-O-(2-[18F]fluoroethyl)-6-O-desmethyl-phenethyl-orvinol
[18F]FE-Tos [18F]fluoroethyl tosylate
Foxy 6-deoxy-6β-fluoro-oxymorphone, «fluorooxymorphone », 4,5α-Epoxy -6β-fluoro-17-methyl-morphinan-3,14-diol, CAS RN: [92593-44-7]
[3H]Foxy [1,2-3H]-4,5α-epoxy-6β-fluoro-17-methyl-morphinan-3,14-diol,
CAS RN: [96917-45-2]
[11C]GR103545 (25) [(3,4-dichlorophenyl)acetyl]-(3R)-(1-pyrrolidinylmethyl)-1-piperazine carboxylic acid methyl-11C ester
[11C]GR89696 (26) 4-[(3,4-dichlorophenyl)acetyl]-3-(R,S)-(1-pyrrolidinylmethyl)-1-piperazine carboxylic acid methyl-11C ester
HD Huntington’s disease
[11C]LAAM (13) N-(methyl-11C)-L-α-acetoxymethadol, N-(methyl-11C)-levo-alpha-acetyl methadol, N-(methyl-11C)-levomethadyl acetate
Leu5-enkephalin H-Tyr-Gly-Gly-Phe-Leu-OH, CAS RN: [58569-55-4]
LY2459989 3-fluoro-4-[4-[[(2S)-2-(3-pyridyl)pyrrolidin-1-yl]methyl]phenoxy] benzamide
LY2795050 3-chloro-4-[4-[[(2S)-2-(3-pyridyl)pyrrolidin-1-yl]methyl]phenoxy] benzamide,
CAS RN: [1346133-08-1]
LY2456302 (34) (S)-4-(4-((2-(3,5-dimethylphenyl)pyrrolidin-1-yl)methyl)phenoxy)- 3-fluorobenzamide, CERC-501, CAS RN: [1174130-61-0]
LY2940094 ([2-[4-[(2-chloro-4,4-difluoro-spiro[5H-thieno[2,3-c]pyran-7,4′-piperidine]-
1′-yl)methyl]-3-methyl-pyrazol-1-yl]-3-pyridyl]methanol), BTRX-246040,
CAS RN: [1307245-86-0]
Met5-enkephalin H-Tyr-Gly-Gly-Phe-Met-OH
[11C]MeJDTic (29) (3S)-7-hydroxy-N-((1S)-1-[[3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-
1-piperidinyl]methyl]-2-methylpropyl)-2-[11C]methyl-1,2,3,4-tetrahydro-
3-isoquinolinecarboxamide
[11C]MeNTI (22) [11C]methyl-naltrindole, N1’-[11C]methyl-naltrindole
[18F]MK-0911 (39) 1-(2-[18F]fluoroethyl)-3-[(3R,4R)-3-(hydroxymethyl)-1-[[(8S)-spiro[2.5]octan-8-yl]
methyl]piperidin-4-yl]benzimidazol-2-one
MPTP 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, CAS RN: [28289-54-5]
Oxycodone 14-hydroxy-dihydrocodeinone, CAS RN: [76-42-6]
Naloxone N17-allyl-14-hydroxy-dihydromorphinone, N17-Allyl-noroxymorphone,
CAS RN: [465-65-6]
Naltrexone N17-cyclopropylmethyl-14-hydroxy-dihydromorphinone,
N17-cyclopropylmethyl-noroxymorphone, NTX
CAS RN: [16590-41-3]
Nociceptine Phe-Gly-Gly-Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-Leu-Ala-Asn-Gln
N-substituted-
[11C]quinolinimide (24)
6-(2-{2-[4-(4-fluorobutyl)-benzenesulfonyl]-1,2,3,4-tetrahydro-isoquinolin-1-yl} -ethyl)-2-[11C]methyl-pyrrolo[3,4-b]pyridine-5,7-dione
NTI naltrexone-indole, naltrindole, CAS RN: [111555-53-4]
[11C]NOP-1A (36) (2S)-2-[(2-fluorophenyl)methyl]-3-(2-fluorospiro[4,5-dihydro-thieno[2,3-c]pyran- 7,4'-piperidine]-1'-yl)-N-[11C]methyl-propanamide
OR opioid receptor
[11C]PEO (18) [11C]phenethyl-orvinol, [6-O-methyl-11C]phenethyl-orvinol
PET positron emission tomography
Pd2dba3 Pd2(dba)3, tris(dibenzylideneacetone)dipalladium, CAS RN: [51364-51-3]
[3H]PL017 [3,5-3H]Tyr-Pro-(NMe)Phe-d-Pro-NH2, 3-N-Me-Phe-[3H]morphiceptin,
[3H] [MePhe3,D-Pro4]morphiceptin
Salvinorin A methyl (2S,4aR,6aR,7R,9S,10aS,10bR)-9-acetyloxy-2-(furan-3-yl)-6a,10b-dimethyl- 4,10-dioxo-2,4a,5,6,7,8,9,10a-octahydro-1H-benzo[f]isochromene-7-carboxylate, CAS RN: [83729-01-5]
TBDMS tert-butyldimethylsilyl protecting group
TDBPN 3-O-trityl-6-O-desmethyl-buprenorphine, CAS RN: [157891-93-5]
TDDPN 3-O-trityl-6-O-desmethyl-diprenorphine, CAS RN: [157891-92-4],
Luthra-precursor”, TDDPN was the first product of the company ABX advanced biochemical compounds Biomedizinische Forschungsreagenzien GmbH, Radeberg in 1997
TDPEO 3-O-trityl-6-O-desmethyl-phenethyl-orvionol, CAS RN: [1187551-69-4]
U-50488 3,4-dichloro-N-methyl-N-[(1R,2R)-2-(1-pyrrolidinyl)cyclohexyl]- benzene acetamide, NIH10533, CAS RN: [67198-13-4]